Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.4559
-0.0088 (-1.89%)
At close: Apr 2, 2026, 4:00 PM EDT
0.4467
-0.0092 (-2.02%)
After-hours: Apr 2, 2026, 7:56 PM EDT
Fractyl Health Stock Forecast
GUTS's stock price has decreased by -58.93% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts that cover Fractyl Health stock have a consensus rating of "Strong Buy" and an average price target of $5.40, which forecasts a 1,084.47% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $8.00.
Price Target: $5.40 (+1,084.47%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Fractyl Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +1,654.77% | Mar 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $8 → $2 | Buy → Hold | Downgrades | $8 → $2 | +338.69% | Jan 30, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +1,654.77% | Dec 2, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $8 | Strong Buy | Maintains | $6 → $8 | +1,654.77% | Nov 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +1,654.77% | Sep 26, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
22.77M
EPS This Year
-0.70
from -1.86
EPS Next Year
-0.66
from -0.70
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | 75.0M | |||
| Avg | n/a | 22.8M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.57 | -0.53 | |||
| Avg | -0.70 | -0.66 | |||
| Low | -0.86 | -0.83 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.